<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="editorial" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-1874</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРЕСС-РЕЛИЗ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ПРЕСС-РЕЛИЗ</subject></subj-group></article-categories><title-group><article-title>Исследование HYVET— важнейшее клиническое исследование 2008 г в рейтинге Общества Клинических Исследований и Американской Ассоциации Сердца</article-title><trans-title-group xml:lang="en"><trans-title>HYVET Study — the most important clinical trial of 2008, as rated by the Society for Clinical Trials and the American Heart Association</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Редакционная</surname><given-names>статья</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>20</day><month>10</month><year>2009</year></pub-date><volume>8</volume><issue>5</issue><fpage>113</fpage><lpage>114</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Редакционная с., 2009</copyright-statement><copyright-year>2009</copyright-year><copyright-holder xml:lang="ru">Редакционная с.</copyright-holder><copyright-holder xml:lang="en">Редакционная с.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/1874">https://cardiovascular.elpub.ru/jour/article/view/1874</self-uri><abstract><p>4 мая 2009г, Атланта, Джорджия, США</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-98.</mixed-citation><mixed-citation xml:lang="en">Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-98.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">United Nations. World population ageing 1950-2050. IV. Demographic profile of the older population. Available from http://www.un.org/esa/population/publications/worldage-ing19502050/pdf/90chapteriv.pdf.</mixed-citation><mixed-citation xml:lang="en">United Nations. World population ageing 1950-2050. IV. Demographic profile of the older population. Available from http://www.un.org/esa/population/publications/worldage-ing19502050/pdf/90chapteriv.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Leonetti G, Emeriau J-P, Knauf H, et al. Evaluation of longterm efficacy and acceptability of indapamide SR in elderly hypertensive patients. Curr Med Res Opin 2005; 21: 37-46.</mixed-citation><mixed-citation xml:lang="en">Leonetti G, Emeriau J-P, Knauf H, et al. Evaluation of longterm efficacy and acceptability of indapamide SR in elderly hypertensive patients. Curr Med Res Opin 2005; 21: 37-46.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a doubleblind, placebo controlled trial. Lancet 2008; 7:683-9.</mixed-citation><mixed-citation xml:lang="en">Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a doubleblind, placebo controlled trial. Lancet 2008; 7:683-9.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">American Heart Association. News release. Top research advances include studies that influence medical care, apply science to ‘real world’ communities. January 21, 2009. Available from http://americanheart.mediaroom.com/index.php?s=43&amp;item=648.</mixed-citation><mixed-citation xml:lang="en">American Heart Association. News release. Top research advances include studies that influence medical care, apply science to ‘real world’ communities. January 21, 2009. Available from http://americanheart.mediaroom.com/index.php?s=43&amp;item=648.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Medscape Cardiology. This Year’s Awards for the Most Important Trials Go to... HYVET and ACCOMPLISH. March 2, 2009. Available from http://cme.medscape.com/viewarticle/588818</mixed-citation><mixed-citation xml:lang="en">Medscape Cardiology. This Year’s Awards for the Most Important Trials Go to... HYVET and ACCOMPLISH. March 2, 2009. Available from http://cme.medscape.com/viewarticle/588818</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Faculty of 1000 Medicine. All time Top 10 by F1000 factor. All of Medicine. March 30, 2009. Available from http://www.f1000medicine.com/top10/classics/</mixed-citation><mixed-citation xml:lang="en">Faculty of 1000 Medicine. All time Top 10 by F1000 factor. All of Medicine. March 30, 2009. Available from http://www.f1000medicine.com/top10/classics/</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension. Drugs Safety 2001; 24: 1155-65.</mixed-citation><mixed-citation xml:lang="en">Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension. Drugs Safety 2001; 24: 1155-65.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
